Latest filing published 02 Jun 2026 for MiNK Therapeutics, Inc., €15k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Brian Corvese (board member) discloses dealings in 2 companies, chiefly MiNK Therapeutics, Inc. and Agenus Inc. Over a trading history stretching from 16 June 2021 to 1 June 2026, the count stands at 17 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 2 June 2026 with a share grant (€15k) in MiNK Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
17 of 17 declarations